President Donald Trump speaks during a news conference on the North Portico of the White House, Monday, Sept. 7, 2020 (Patrick Semansky/AP Images)
September 8, 2020 06:35 AM EDTUpdated 10:56 AM
Bioregnum
Coronavirus
Opinion

CEOs join reg­u­la­tors and top sci­en­tists vow­ing to hold the line on Covid-19 vac­cine. But will that get in the way of Trump's 'big sur­prise'?

Nine top de­vel­op­ers lead­ing the race to de­vel­op a vac­cine to com­bat Covid-19 are pre­sent­ing a uni­fied front this morn­ing as they joint­ly com­mit …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times